A Phase I Study Evaluating the Effect of a High Fat Meal on the Pharmacokinetics of Cabotegravir in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Cabotegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 23 Sep 2016 Status changed from active, no longer recruiting to completed.
- 22 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Aug 2016.
- 22 Aug 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2016.